BEIJING, China, Aug. 01, 2025 — Pheton Holdings Ltd (referred to as “the Company,” “we,” “our,” or “Pheton”), a healthcare solution provider focused on treatment planning systems for brachytherapy and associated products and services, released the subsequent statements on August 1, 2025. This was done to address recent market fluctuations and a third-party report that has caused uncertainty and worry among its investors.

In recent days, Pheton’s share price has seen an unusual and sharp drop. The Company attributes this decline possibly to a speculative article issued by The Bear Cave on July 29, 2025. This article claimed that Pheton’s stock value might have been affected by untrue rumors concerning a possible takeover by Gilead Sciences, Inc. (“Gilead”).

Management’s Stance and Explanation

Pheton’s leadership firmly and completely refutes any participation in or awareness of stock price manipulation. The Company has never engaged in, started, or endorsed any rumors, discussions, or actions concerning an acquisition by Gilead or any other entity. Pheton confirms no communication with Gilead, and any assertions or reports indicating otherwise are, and always have been, completely untrue and invented.

Furthermore, Pheton intends to collaborate with its market makers, Nasdaq, and pertinent regulatory authorities to ensure that those responsible for this scheme are held answerable.

Safeguarding Shareholder Investments

We acknowledge the apprehension this event has created among our investors. Consequently, we are reviewing our internal controls and communications to guarantee that any subsequent false information can be promptly and efficiently addressed.

Dedication to Openness and Expansion

Pheton is dedicated to maintaining the utmost levels of corporate governance, openness, and responsibility. Consistent with our approach, we continue to prioritize building long-term value for shareholders through strategic growth opportunities that align with our objectives and enhance our market standing.

Pheton’s foundation is built on trust, innovation, and generating value, and the Company retains strong confidence in its fundamental business, its long-term strategic direction, and the commitment of its personnel.

Message to Our Investors

We greatly appreciate the confidence our shareholders have in us. We are committed to consistently providing the investor community with precise and prompt information. Our leadership remains concentrated on executing operations and bolstering the credibility of our public market standing.

Regarding Pheton Holdings Ltd

Established in 1998, Pheton Holdings Ltd, via its wholly-owned operational subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd. (“Beijing Feitian”), specializes in healthcare solutions for brachytherapy, which is a localized radiation therapy used for cancer treatment. Beijing Feitian’s Treatment Planning System, its primary offering, facilitates secure and efficient brachytherapy by employing radioactive sources within the patient to destroy cancer cells and reduce tumor size. Pheton aims to utilize its offerings to potentially set a new benchmark for care in various malignant tumor treatments. For additional details, please visit:

Statements Regarding the Future

This announcement contains certain statements that look to the future. Such forward-looking statements include various known and unknown risks and uncertainties, and they are founded on the Company’s current expectations and forecasts concerning future occurrences that the Company believes could impact its financial health, operational outcomes, business approach, and financial requirements. Investors can identify these statements by terms or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may,” or similar language. The Company is not obligated to publicly update or amend any forward-looking statements to reflect subsequent events or changes in its expectations, unless legally mandated. While the Company considers the expectations conveyed in these forward-looking statements to be reasonable, it cannot guarantee their accuracy, and the Company advises investors that actual results might differ significantly from projected outcomes. Investors are encouraged to examine other factors that could influence future results in the Company’s submissions to the U.S. Securities and Exchange Commission.

For investor and press inquiries, please reach out to:

Pheton Holdings Ltd
Investor Relations
Email:

Jackson Lin
Lambert by LLYC
Tel: +1 (646) 717-4593
Email:

###